The Decade of Vaccine Economics (DOVE) study has revealed significant household costs associated with childhood diseases and policy makers are taking notice.
Read More >
The WHO recommends all countries include the human papillomavirus (HPV) vaccine in their national immunization program and many low- and middle-income countries are moving to introduce HPV vaccine into their national immunization programs.
Read More >
Immunization programs are widely understood as the driving force and foundation for building both primary care and universal health care systems for all. The challenges ahead are serious, substantial, and stubborn. These include increasing numbers of people living in humanitarian emergencies, massive increases in the urban poor, and the impact of climate change.
Read More >
When it comes to stopping childhood pneumonia, the odds are stacked against the poor and vulnerable; but vaccines can give them a fighting chance. In 2009, approximately 3,400 children died of pneumonia every day. Now, with investments in pneumonia prevention and treatment – including the introduction and scale up of two vaccines to prevent the most common causes of pneumonia death, Haemophilus influenzae type b and pneumococcus – that number has fallen to 1,000.
Read More >